FDA Brief

Warning letters Drugs

FDA warning letter to

Med Shop Inc / www.medshopinc.com

High riskIssued Jun 23Posted Jul 7Center for Drug Evaluation and Research (CDER)

FDA warned Med Shop Inc that its website sells unapproved, misbranded ketamine nasal spray to U.S. consumers.

What happened

FDA reviewed the website www.medshopinc.com on February 27, 2026, rather than doing an inspection. The site offered a product marketed as "Ketamine Nasal Spray" (esketamine) with claims that it treats treatment-resistant depression and chronic pain. FDA said there is no approved application for that product and that its labeling lacks adequate directions for use.

What FDA found

  1. The company sells a ketamine nasal spray without an FDA-approved application, which the law requires for a new drug.

    FD&C Act sections 301(d) and 505(a) (21 U.S.C. 331(d), 355(a))
  2. Website statements that the spray treats depression and chronic pain show the product is a drug intended for human use.

    FD&C Act section 201(g) (21 U.S.C. 321(g)); 21 CFR 201.128
  3. The product's labeling does not give adequate directions for use, so it is misbranded.

    FD&C Act section 502(f)(1) (21 U.S.C. 352(f)(1))
  4. The drug is a prescription drug that a layperson cannot safely use on their own, and it has no exemption from the directions-for-use requirement because it is not approved.

    FD&C Act section 503(b)(1) (21 U.S.C. 353(b)(1)); 21 CFR 201.115(a)
  5. Offering the misbranded drug for sale to U.S. consumers puts it into interstate commerce illegally.

    FD&C Act section 301(a) (21 U.S.C. 331(a))

What FDA wants

FDA tells the company to stop offering unapproved and misbranded drugs to U.S. consumers and to reply in writing within 15 business days with the steps taken to correct and prevent the violations, plus supporting documents, citing reference number MARCS-CMS 725157.

Who should pay attention

  • online pharmacies and telehealth sites selling ketamine products
  • U.S. clinicians whose patients buy ketamine online
  • distributors and compounders shipping ketamine products to U.S. buyers

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Bella’s Nutri Shop Inc.

    Bella’s Nutri Shop sells “Tawon Liar” as an unapproved drug with hidden dexamethasone, tapentadol, and meloxicam.

    High risk
  4. Jing Cheong Asia Inc. dba New York Tong Ren Tang

    New York Tong Ren Tang marketed unapproved new drugs, including eye drops, on its website.

    High risk